Navigation Links
Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
Date:9/21/2010

ments are based on certain assumptions made by the Company based on its management's experience and perception of historical trends, current conditions, expected future developments and other factors the Company's management believes are appropriate in the circumstances. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the Company's control, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements.  These risks, uncertainties and contingencies include, but are not limited to, the following: productivity levels, margins earned and the level of operating costs; weakness in global economic conditions or in customers' industries; changes in governmental regulation of the mining industry or the electric power industry and the increased costs of complying with those changes; decreases in demand for electricity and changes in coal consumption patterns of U.S. electric power generators; the Company's dependence on a limited number of customers; the Company's inability to enter into new long-term coal sales contracts at attractive prices and the renewal and other risks associated with the Company's existing long-term coal sales contracts, including risks related to adjustments to price, volume or other terms of those contracts; difficulties in collecting the Company's receivables because of credit or financial problems of major customers, and customer bankruptcies, cancellations or breaches to existing contracts, or other failures to perform; the Company's ability to acquire additional coal reserves; the Company's ability to respond to increased competition within the coal industry; fluctuations in coal demand, prices and availability due to labor and transportation costs and disruptions, equipment availability and/or governmental regulations; significant costs imposed on the Company's mining operations by extensive environmental laws and regulations, an
'/>"/>
SOURCE Oxford Resource Partners, LP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
2. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
3. Oxford BioTherapeutics Appoints Michael Moore as Chairman
4. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
5. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
6. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
7. Bavarian Nordics Case Against Oxford BioMedica
8. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
9. New resource examines questions about the role of nanoscience
10. Web Resource for Interferon Research
11. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  (PSHR) Pacific Shore ... based products across a broad range of product ... retained investor relations firm, BlueWater Advisory Group, to ... to trading process, and to direct the company,s ... Matthew Mills , ...
(Date:5/20/2013)... , May 20, 2013 Pacific Biomarkers and Clinigene ... for developers of biosimilars at the 2013 AAPS/ ... San Diego Hotel and Marina , ... have the opportunity to speak with company representatives at ... That Cross" on May 21 from 1-2 p.m. in ...
(Date:5/20/2013)... BALTIMORE , May 20, 2013 ... regional private-public partnership focusing on commercializing market-relevant biohealth ... Central Maryland , today announced ... the first Entrepreneur-in-Residence (EIR) for BHI at the ... Lung and Blood Institute (NHLBI). Dr. Aiyar ...
(Date:5/20/2013)...   Flexion Therapeutics , Inc. today announced the ... to its management team as chief financial officer. Mr. ... experience with biotechnology and medical device companies. ... officer for Novavax (NASDAQ: NVAX ) where ... million through a combination of investment funding and commercial ...
Breaking Biology Technology:Pacific Shore Holdings Retains Investor Relations Firm 2Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2
... at The University of Texas at Austin have conducted a ... test tube, measuring a thousandth the diameter of a human ... a high-power electron microscope was required to see the experiment. ... tube was stuffed with a thread-like crystal (a nanowire) of ...
... Oct. 15 Amgen (Nasdaq: AMGN ) today announced ... on Wednesday, Oct. 21, 2009 after the close of the ... call with the investment community at 2 p.m. Pacific Time. ... Sharer, chairman and chief executive officer, and other members of ...
... Oct. 15 Today, Formatech, Inc. announced that ... ("Company") HIV/AIDS vaccine will be the first clinical candidate that ... production run is scheduled to be completed in January 2010. ... to aseptically fill and finish one lot of the vaccine ...
Cached Biology Technology:Tiny test tube experiment shows reaction of melting materials at the nano scale 2Amgen Announces Webcast of 2009 Third Quarter Financial Results 2Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 2Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 3Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program' 4
(Date:5/21/2013)... of "place" is increasingly being considered in the ... a new resource that can help them recognize ... the places in their lives. , Place-Based ... book co-edited by the Pacific Northwest Research Station,s ... approach to conservation. The book is published by ...
(Date:5/21/2013)... Wash. A new analysis shows that the nation,s ... of enough algae to produce up to 25 billion ... States, one-twelfth of the country,s yearly needs. , The ... resources that would be needed to grow significant amounts ... results were published in the May 7 issue of ...
(Date:5/21/2013)... infections occur in the body, stem cells in ... and differentiating into mature immune cells that can ... can deplete these cell populations, potentially leading to ... cancer. Now, a team of researchers led by ... has found that, in mouse models, the molecule ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Keeping stem cells strong 2
... the December issue of the journal Cell Metabolism, published ... which the mammary glands of mammals meet the incredible ... of breast development undoubtedly affect breast cancer, the findings ... researchers found that one of three “isoforms?of the gene ...
... in 1966 in Kenya. It has since been reported ... disease is characterized by the appearance of mottling and ... development of seeds are affected, which causes considerable yield ... by way of insect vectors or by straightforward contact ...
... People with HIV have been living longer, healthier lives since ... 1995. In fact, most patients on the drug regimen do ... appear to return to pre-HIV levels. But two new studies ... (ADARC) show that the immune cells in other body tissues ...
Cached Biology News:How mammals fuel milk production may have implications for cancer 2How mammals fuel milk production may have implications for cancer 3Discovery of the first resistance gene to rice yellow mottle virus 2Discovery of the first resistance gene to rice yellow mottle virus 3HIV-1 kills immune cells in the gut that may never bounce back 2HIV-1 kills immune cells in the gut that may never bounce back 3
... of gene expression) technology allows ... profiles generated by SAGE are ... transcripts making it possible to ... Kit is designed to make ...
Incomplete Adjuvant...
2,4-Dinitrophenyl hapten is conjugated to Keyhole Limpet (KLH) protein through lysine....
...
Biology Products: